HOME >> MEDICINE >> NEWS
Tuberculosis drug combined with virtual reality therapy is effective in treating fear of heights

A tuberculosis drug called D-cycloserine (DCS), used in concert with psychotherapy, is an effective treatment for some anxiety-related disorders, according to research by scientists at Emory University School of Medicine and the Center for Behavioral Neuroscience (CBN). The study was led by Michael Davis, PhD, Kerry Ressler, MD, PhD, and Barbara Rothbaum, PhD, of the Department of Psychiatry and Behavioral Sciences and is reported in the November issue of the Archives of General Psychiatry.

In the study of 28 people suffering from acrophobia, which is an abnormal fear of heights, either DCS or placebo was given to study participants, followed by two virtual reality sessions that simulated standing in a rising glass elevator. Compared to subjects who took only placebo, those treated with DCS experienced a significant reduction in their fear of heights that was maintained for at least three months (the longest time tested) after concluding therapy.

The mechanisms governing the fear response, located in a region of the brain called the amygdala, function abnormally in an acrophobic's brain. DCS binds to neurotransmitter receptors in the amygdala called NMDA (N-methyl-D-aspartate) receptors. When combined with virtual reality exposure therapy, DCS facilitates fear extinction in the acrophobic's brain.

"Cognitive behavioral psychotherapy uses a process called 'fear extinction' to treat individuals with phobias, as well as more complicated problems, such as post-traumatic stress syndrome," said Dr. Davis.

"Fear extinction involves repeated exposure to a fearful memory or object, in the absence of adverse consequences. Because it was known that DCS improves NMDA synaptic transmission and we found it improved extinction in rats, we hoped to facilitate the effects of cognitive behavioral therapy by combining DCS with virtual reality therapy in humans. Our results demonstrate that this combination is effective, and that these effects can be long lasti
'"/>

Contact: Kathi Baker
kobaker@emory.edu
404-727-9371
Emory University Health Sciences Center
5-Nov-2004


Page: 1 2

Related medicine news :

1. Tuberculosis strains stay close to home, say Stanford researchers
2. UCSD Medical Center receives NIH contract to set up National Tuberculosis Educational Curriculum
3. Tuberculosis Foundation selects Core Research Scientists
4. Bevacizumab combined with chemotherapy prolongs survival for some patients with advanced lung cancer
5. Detrol LA combined with standard treatment for enlarged prostate is twice as effective
6. Nicotine more addictive when combined with other tobacco smoke chemicals, UCI study finds
7. Cognitive behavioral therapy combined with antidepressant effective in treating adolescent OCD
8. Heart disease kills more women annually than all cancers combined
9. Stents combined with clot-busting drugs effective in limiting impact of deadly form of stroke
10. Study shows people with Alzheimers can benefit from exercise combined with caregiver training
11. Wyeth chemists honored for Prevnar first combined pneumococcal vaccine for infants

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/15/2018)... ... September 14, 2018 , ... Last night, Congressional leadership ... appropriations for Labor, Health and Human Services and Education (LHHS) and Defense. Specifically, ... (TPP) Program, and $286.5 million for the Title X Family Planning Program for ...
(Date:9/13/2018)... ... September 13, 2018 , ... Pulsara is honored to ... + Revenue Cycle Conference on September 19-22 in Chicago. Dr. Woodson, ER Physician ... well as a talk titled, “Your Clinical Communication & Collaboration (CC&C) is Not Enough: ...
(Date:9/12/2018)... ... September 12, 2018 , ... Definitive Healthcare , the leading provider of ... tournament supporting the Dana-Farber Cancer Institute and the Jimmy Fund. , “It’s a ... director. “I’m happy we have such wonderful sponsors and volunteers. The growth we’ve seen ...
(Date:9/7/2018)... LOS ANGELES (PRWEB) , ... September 07, 2018 ... ... dietary supplements, household and personal-care products with a presence worldwide, today announced that ... Alumni Industry Excellence Award in Entrepreneurship. Ms. Ishaq will be presented the award ...
(Date:9/7/2018)... ... September 07, 2018 , ... The Ramsey Keller ... its first-ever national retreat for moms who are living without a child. “ The ... weekend of October 26, 27 and 28 at Fairmont Hot Springs Resort ...
Breaking Medicine News(10 mins):
(Date:9/15/2018)... ... September 14, 2018 , ... ... in Africa, and Axa Insurance Morocco (“AXA”), have signed an agreement to ... institutional shareholder. The capital raise will help enhance the company’s footprint in ...
(Date:9/15/2018)... ... September 14, 2018 , ... "As of Thursday, Sept. 13, 2018, ... Hurricane Florence. I am planning this Women of Influence tour with the knowledge that ... and knowing I have to hold onto my faith through this storm. So many ...
(Date:9/13/2018)... ... September 13, 2018 , ... Dr. Rod J. Rohrich is ... Meeting. The Meeting, which draws rhinoplasty experts from around the world, will take place ... topics from the fundamentals of nasal anatomy to complex surgical procedures and detailed analysis ...
Breaking Medicine Technology:
Cached News: